Back

Outcomes of COVID-19 patients with STEMI undergoing primary PCI

29 August 2022 (11:15 - 11:55)
Organised by:
Congress Presentation Part of: Coronary artery disease - Epidemiology, prognosis, outcome 7 Revascularisation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Pawel Kleczynski

St. John Paul II Hospital, Krakow (Poland)

5 More presentations in this session

Presentation thumbnail
Prognosis following acute coronary syndrome according to cancer type and status - a nationwide Danish cohort study
Doctor N. Nouhravesh (Durham, US)
Abstract Slides
Presentation thumbnail
Medical therapy for secondary prevention in patients with myocardial infarction with non-obstructive coronary artery disease: long-term outcome of a Portuguese centre
Doctor D. De Campos (Coimbra, PT) Doctor C. Saleiro (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Impact of in-hospital medical management for COVID-19 pandemic on door-to-balloon time in patients with ST-elevation myocardial infarction
Doctor A. Takasaki (Tsu, JP)
Abstract Slides
Presentation thumbnail
Effects of mask-wearing on treadmill exercise test
Doctor H. Chang (Taipei, TW)
Abstract Slides
Presentation thumbnail
Impact of dexamethasone on cardiac injury in critically ill COVID-19 patients
Doctor V. van Almsick (Muenster, DE)
Abstract Slides

Access the full session

Session thumbnail
Coronary artery disease - Epidemiology, prognosis, outcome 7

The Event

Event poster

ESC Congress 2022

29 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Primary percutaneous coronary intervention in a regional centre: pandemic impact
21 March 2026
thumbnail
Congress Presentation
Outcomes of COVID-19 infection in heart transplant recipients
27 August 2021
thumbnail
Congress Presentation
Clinical outcomes, predictors and prognostic impact of acute heart failure in patients with ST elevation myocardial infarction
21 May 2023
thumbnail
Congress Presentation
Early outcome in patients with STEMI undergoing primary PCI and high Zwolle risk score discharged within 72 hours
8 March 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources